Establishment Labs Holdings Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG00L8R3CR6
ESTA
Establishment Labs Holdings Inc.
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Medical Devices
NAME
Establishment Labs Holdings Inc.
ISIN
VGG312491084
TICKER
ESTA
MIC
XNAS
REUTERS
ESTA.OQ
BLOOMBERG
ESTA US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Wed, 26.02.2025
Establishment Labs
VGG312491084
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the fourth quarter and full year ended December 31, 2024 and reaffirmed 2025 guidance.
Fourth Quarter Highlights and Ou...
Establishment Labs
Tue, 25.02.2025
Establishment Labs
VGG312491084
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in TD Cowen's 45th Annual Health Care Conference.
Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Den...
Establishment Labs
Fri, 21.02.2025
Establishment Labs
VGG312491084
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in a fireside chat at Citi's 2025 Unplugged Medtech and Life Sciences Access Day.
Juan José Chacón-Quirós, Chief Executive O...
Establishment Labs
Tue, 18.02.2025
Establishment Labs
VGG312491084
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness in breast aesthetics and reconstruction, announced it has launched Preservé™ in Brazil, the first country in its global rollout. Preservé is the second product in the Company’s minimally invasive platform, buildin...
Establishment Labs
Fri, 14.02.2025
Establishment Labs
VGG312491084
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended December 31, 2024, after the market closes on Wednesday, February 26, 2025, and will host a confe...
Establishment Labs
Mon, 13.01.2025
Establishment Labs
VGG312491084
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness in breast aesthetics and reconstruction, announced today that after twenty years as Chief Executive Officer (CEO), Juan José Chacón-Quirós has decided to retire as CEO, effective March 1, 2025. Peter Caldini, curr...
Establishment Labs
Tue, 07.01.2025
Establishment Labs
VGG312491084
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the 43rd Annual J.P...
Establishment Labs
Mon, 11.11.2024
Establishment Labs
VGG312491084
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in three upcoming investment conferences.
Juan José Chacón-Quirós, Chief Executive Officer and Founder, and Raj Denhoy, Chi...
Establishment Labs
Thu, 07.11.2024
Establishment Labs
VGG312491084
Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with select purchasers for the purchase of ...
Establishment Labs
Thu, 07.11.2024
Establishment Labs
VGG312491084
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2024.
Third Quarter Highlights and Outlook
Third quarter worldwide revenue of $4...
Establishment Labs
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
